- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00716872
Improving the Sleep of Cancer Patients Using an Internet-Based Program (SHUTi-C)
24 februari 2010 bijgewerkt door: University of Virginia
Evaluating Internet-Based Interventions for Insomnia in Cancer Patients
The purpose of this study is to determine whether an Internet-based program, Sleep Healthy Using the Internet (SHUTi, or "Shut-Eye"), can help to improve the sleep of people who are in remission from cancer and experiencing symptoms of insomnia.
Studie Overzicht
Toestand
Voltooid
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The purpose of this study is to test the feasibility of using an Internet program to improve the sleep of cancer patients with insomnia.
Participants will receive access to the Internet program (called SHUTi, or "Shut-Eye") as well as to self-hypnosis recordings designed to improve sleep.
SHUTi provides an online, tailored educational program to individuals who are experiencing sleep difficulties, including those having difficulty falling asleep, waking in the middle of the night, and waking too early in the morning.
Studietype
Ingrijpend
Inschrijving (Verwacht)
22
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
Virginia
-
Charlottesville, Virginia, Verenigde Staten, 22908
- University of Virginia Department of Psychiatry & Neurobehavioral Sciences
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
21 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Age = At least 21 years old
- Regular access to the Internet, including e-mail
Cancer patient
- Any type of cancer (EXCEPT non-melanoma skin cancer)
- In remission from any stage of cancer (active treatment completed at least one month prior to enrollment)
Insomnia diagnosis (combined from DSM-IV and ICSD):
- Subjective complaints of poor sleep for at least 6 months
- Sleep difficulties ≥3 nights/week
- Difficulty falling asleep (≥30 minutes to fall asleep) OR
Difficulty staying asleep (≥30 minutes awake in the middle of the night)
- ≤6.5 hours sleep/night
- Poor sleep causes marked distress or significant impairment in daytime functioning (e.g. fatigue, performance deficits, mood disturbance)
- Participant feels that the insomnia was caused/aggravated by cancer or cancer treatment
Exclusion Criteria:
- Having a sleep disorder other than insomnia (e.g. sleep apnea, RLS, narcolepsy, parasomnias)
- Having a medical condition other than cancer that causes insomnia
- Experiencing a psychiatric disturbance (major depression, psychosis)
- Experiencing substance abuse
- Currently undergoing psychotherapy or counseling
- Changing sleep/anxiety/depression medication within the past month
Having an "unusual" sleep pattern
- Normal bedtime is after 2am OR
- Normal wake time is after 9am
- Working as a shift worker (that is, having a schedule that requires working through the night)
- Participants reports that she is pregnant or intending to get pregnant in the next 4 months
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: ImmedSHUTi/ImmedHyp
In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away.
In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
|
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I).
Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information.
As they progress through the program, users receive tailored instructions for how to improve their sleep.
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.
|
|
Experimenteel: ImmedSHUTi/DelayHyp
In the first part of the trial, participants are assigned to the Immediate SHUTi group; that is, they receive access to the SHUTi program right away.
In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
|
SHUTi is an Internet program based on cognitive-behavioral therapy for insomnia (CBT-I).
Users complete daily online sleep diaries in addition to receiving weekly access to six interactive "Cores" of information.
As they progress through the program, users receive tailored instructions for how to improve their sleep.
|
|
Experimenteel: DelaySHUTi/ImmedHyp
In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study.
In the second part of the trial (3 months later), participants are assigned to the Immediate Hypnosis group; that is, they receive access to the Hypnosis recordings right away.
|
Subjects listen to self-hypnosis recordings designed to improve their disturbed sleep.
|
|
Geen tussenkomst: DelaySHUTi/DelayHyp
In the first part of the trial, participants are assigned to the Delayed SHUTi group; that is, they receive access to the SHUTi program at the end of the study.
In the second part of the trial (3 months later), participants are assigned to the Delayed Hypnosis group; that is, they receive access to the Hypnosis recordings at the end of the study.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Insomnia Severity Index (ISI)
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Sleep Efficiency
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Total Sleep Time
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
Secundaire uitkomstmaten
Uitkomstmaat |
Tijdsspanne |
|---|---|
|
Sleep Diary: Sleep Onset Latency (SOL)
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Wake After Sleep Onset (WASO)
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Sleep Diary: Number of Nighttime Awakenings
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Hospital Depression and Anxiety Scale
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Pain scale
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Multidimensional Fatigue Symptom Inventory
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Quality of Life (SF-12 Health Survey)
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
|
Hot flashes
Tijdsspanne: prior to intervention, after SHUTi use, after Hypnosis use
|
prior to intervention, after SHUTi use, after Hypnosis use
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Onderzoekers
- Hoofdonderzoeker: Lee M Ritterband, Ph.D., University of Virginia
- Hoofdonderzoeker: Lora D Baum, Ph.D., University of Virginia
- Studie directeur: Elaine T Bailey, Ph.D., University of Virginia
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 juli 2008
Primaire voltooiing (Werkelijk)
1 november 2009
Studie voltooiing (Werkelijk)
1 november 2009
Studieregistratiedata
Eerst ingediend
18 juni 2008
Eerst ingediend dat voldeed aan de QC-criteria
14 juli 2008
Eerst geplaatst (Schatting)
16 juli 2008
Updates van studierecords
Laatste update geplaatst (Schatting)
25 februari 2010
Laatste update ingediend die voldeed aan QC-criteria
24 februari 2010
Laatst geverifieerd
1 februari 2010
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 13685
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .